Skip to main content
Media Alert Press Media Alert Press Check a URL
Saturday, October 24, 2026
Live
Michael Carrick’s monologue was admirable but underlined why he is not the man to revive Man UnitedNeymar, Rivaldo, Romario, Ronaldinho. Can Raphinha trump them all at Barcelona?Jose Mourinho’s start at Real Madrid: Iron-fist or easy-going?Mark Walter reportedly looking to sell WNBA’s Sparks next after Lakers, Chelsea FC salesMavericks star Cooper Flagg injured on flagrant foul by Pacers’ Aaron NesmithBosses or Employees: Who’s More Likely to Use AI and Keep It Secret? A New Study Found the Surprising Answer
48,471 Ledger Records 14 added in the last hour1,564 in the last 24 hours
What is counted?

Counted at 04:37:30 UTC. These figures count ledger entries that have a record hash, the same entries as the total. The newest of them was added at 04:32:42 UTC on 2026-10-24. Entries are added in batches when MAP checks its feeds, so the figures vary through the day.

Technology

Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

By Beth Mole Ars Technica
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Feed excerpt — reported by Ars Technica

Markers released top-line results today after previously reporting the trial succeeded.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Ars Technica →

Original Source

This article was syndicated from Ars Technica. All rights remain with the original publisher.

Powered by CookieAdmin